BSE Live
Dec 05, 15:33Prev. Close
661.50
Open Price
659.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:31Prev. Close
662.00
Open Price
662.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Anthem Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 111.82 | 111.82 | 114.10 | 8.78 | 8.48 | |
| Total Share Capital | 111.82 | 111.82 | 114.10 | 8.78 | 8.48 | |
| Reserves and Surplus | 2,361.40 | 1,821.26 | 1,627.52 | 1,345.04 | 691.35 | |
| Total Reserves and Surplus | 2,361.40 | 1,821.26 | 1,627.52 | 1,345.04 | 691.35 | |
| Total Shareholders Funds | 2,473.21 | 1,933.07 | 1,741.62 | 1,353.82 | 699.83 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 47.03 | 65.72 | 85.06 | 5.90 | 19.72 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 16.94 | 16.64 | 8.34 | 26.71 | 20.26 | |
| Long Term Provisions | 7.20 | 6.53 | 5.39 | 8.06 | 7.41 | |
| Total Non-Current Liabilities | 71.18 | 88.89 | 98.79 | 40.66 | 47.38 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 61.93 | 100.87 | 28.88 | 29.59 | 80.29 | |
| Trade Payables | 110.09 | 100.44 | 71.92 | 64.72 | 76.84 | |
| Other Current Liabilities | 115.34 | 97.60 | 48.26 | 128.74 | 127.75 | |
| Short Term Provisions | 3.82 | 3.35 | 3.55 | 0.00 | 0.00 | |
| Total Current Liabilities | 291.18 | 302.26 | 152.61 | 223.05 | 284.88 | |
| Total Capital And Liabilities | 2,835.56 | 2,324.23 | 1,993.02 | 1,619.18 | 1,033.73 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 620.33 | 471.70 | 439.80 | 322.11 | 354.99 | |
| Intangible Assets | 3.73 | 6.00 | 9.09 | 6.90 | 6.42 | |
| Capital Work-In-Progress | 57.94 | 155.91 | 143.41 | 152.68 | 18.59 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 682.00 | 633.62 | 592.30 | 481.69 | 379.99 | |
| Non-Current Investments | 117.08 | 12.70 | 6.31 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 18.34 | 41.41 | 24.91 | 15.94 | 13.87 | |
| Long Term Loans And Advances | 332.73 | 178.73 | 27.98 | 6.16 | 4.75 | |
| Other Non-Current Assets | 21.35 | 12.27 | 21.90 | 18.31 | 19.32 | |
| Total Non-Current Assets | 1,171.49 | 878.74 | 673.39 | 522.10 | 417.93 | |
| CURRENT ASSETS | ||||||
| Current Investments | 416.14 | 459.07 | 492.87 | 272.98 | 209.27 | |
| Inventories | 338.60 | 211.31 | 129.42 | 58.23 | 35.06 | |
| Trade Receivables | 447.91 | 489.83 | 274.07 | 326.19 | 254.65 | |
| Cash And Cash Equivalents | 310.95 | 183.85 | 342.79 | 348.87 | 40.62 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 150.46 | 101.43 | 80.48 | 90.81 | 76.20 | |
| Total Current Assets | 1,664.07 | 1,445.49 | 1,319.62 | 1,097.08 | 615.81 | |
| Total Assets | 2,835.56 | 2,324.23 | 1,993.02 | 1,619.18 | 1,033.73 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 136.27 | 444.60 | 362.01 | 255.78 | 100.27 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 103.21 | 103.21 | 105.32 | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 117.08 | 12.70 | 6.31 | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
14.08.2025
Anthem Bio shares surge 5 percent on strong show in CRDMO and specialty business
21.07.2025
Anthem Biosciences shares close with 28% gains on market debut, valued at Rs 41,017 crore
21.07.2025
Anthem Biosciences shares list at 27% premium over IPO price on NSE; should you buy, sell or hold?
21.07.2025